Health Canada drug identification number

DIN 02561824 — SEPHIENCE 250 MG

SEPHIENCE is a powder of Sepiapterin marketed by PTC THERAPEUTICS INTERNATIONAL LIMITED. The full Sepiapterin monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.

DIN
02561824
Brand name
SEPHIENCE
Active ingredient
Sepiapterin
Strength
250 MG
Dosage form
POWDER
Route
ORAL
Manufacturer
PTC THERAPEUTICS INTERNATIONAL LIMITED
Health Canada status
MARKETED
Drug class
Tetrahydrobiopterin (BH4) precursor for phenylketonuria

Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.

Other Sepiapterin products

DINBrandStrengthFormManufacturerStatus
02561832 SEPHIENCE 1000 MG POWDER PTC THERAPEUTICS INTERNATIONAL LIMITED MARKETED

Rejoining the server...

Rejoin failed... trying again in seconds.

Failed to rejoin.
Please retry or reload the page.

The session has been paused by the server.

Failed to resume the session.
Please retry or reload the page.